共 60 条
[1]
Connolly KR(2011)If at first you don’t succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies Drugs. 71 43-64
[2]
Thase ME(2008)Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment World J Biol Psychiatry. 9 102-114
[3]
Moller HJ(2011)Treatment-resistant depression: prevalence, risk factors, and treatment strategies J Clin Psychiatry 72 e18-90
[4]
Thase ME(2009)A systematic review of augmentation strategies for patients with major depressive disorder Psychopharmacol Bull 42 57-S37
[5]
Fleurence R(2013)Atypical antipsychotic augmentation strategies in the context of guideline-based care for the treatment of major depressive disorder CNS Drugs. 27 S29-649
[6]
Williamson R(2012)Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder Ann Pharmacother 46 642-1598
[7]
Jing Y(2012)Treatment-emergent adverse events associated with atypical antipsychotics Expert Opin Pharmacother 13 1587-359
[8]
Patkar AA(2013)Augmentation with atypical antipsychotics for depression: a review of evidence-based support from the medical literature Pharmacotherapy. 33 344-98
[9]
Pae CU(2014)A systematic review and meta-analysis of the evidence base for add-on treatment for patients with major depressive disorder who have not responded to antidepressant treatment: a European perspective J Psychopharmacol. 28 85-1065
[10]
Taneja C(2014)Use of augmentation agents for treating depression: analysis of a psychiatric electronic medical record data set Psychiatr Serv 65 1062-134